Mackenzie Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$64.7M Sell
250,706
-7,569
-3% -$1.95M 0.08% 200
2025
Q1
$57.8M Buy
258,275
+93,794
+57% +$21M 0.08% 198
2024
Q4
$37.6M Sell
164,481
-47,952
-23% -$11M 0.05% 250
2024
Q3
$51.9M Buy
212,433
+45,278
+27% +$11.1M 0.07% 219
2024
Q2
$32M Buy
167,155
+19,995
+14% +$3.83M 0.05% 271
2024
Q1
$29.1M Sell
147,160
-20,605
-12% -$4.08M 0.04% 282
2023
Q4
$28.9M Buy
167,765
+16,260
+11% +$2.8M 0.04% 279
2023
Q3
$21.9M Buy
151,505
+16,966
+13% +$2.45M 0.04% 300
2023
Q2
$28.9M Sell
134,539
-602
-0.4% -$129K 0.04% 273
2023
Q1
$29.6M Buy
135,141
+115,773
+598% +$25.4M 0.05% 282
2022
Q4
$4.03M Buy
19,368
+1,618
+9% +$337K 0.01% 551
2022
Q3
$3.88M Sell
17,750
-1,283
-7% -$280K 0.01% 567
2022
Q2
$3.99M Sell
19,033
-478
-2% -$100K 0.01% 576
2022
Q1
$4.73M Buy
19,511
+2,445
+14% +$593K 0.01% 588
2021
Q4
$4.45M Sell
17,066
-398
-2% -$104K 0.01% 602
2021
Q3
$4.6M Sell
17,464
-3,591
-17% -$946K 0.01% 582
2021
Q2
$5.19M Sell
21,055
-1,375
-6% -$339K 0.01% 553
2021
Q1
$4.35M Buy
22,430
+4,307
+24% +$836K 0.01% 562
2020
Q4
$3.85M Buy
18,123
+1,935
+12% +$411K 0.01% 488
2020
Q3
$2.78M Buy
16,188
+5,991
+59% +$1.03M 0.01% 494
2020
Q2
$1.96M Buy
10,197
+4,852
+91% +$932K 0.01% 563
2020
Q1
$787K Sell
5,345
-55
-1% -$8.1K ﹤0.01% 699
2019
Q4
$837K Buy
5,400
+3,306
+158% +$512K ﹤0.01% 763
2019
Q3
$283K Sell
2,094
-10
-0.5% -$1.35K ﹤0.01% 899
2019
Q2
$257K Sell
2,104
-50
-2% -$6.11K ﹤0.01% 987
2019
Q1
$224K Buy
+2,154
New +$224K ﹤0.01% 1146